Life-saving procedure brings hope for the patient with a blood disorder

Ensure quality of stem cells in the Regenerative Medicine laboratory at The Medical City. The medical city

A forty-year-old patient was revived after undergoing a procedure that helped her fight a life-threatening condition.

The symptoms of the patient Mary, not her real name, started as persistent back pain and chest pain, which she thought were caused by heart disease.

However, the result of her blood and other diagnostic tests led to the diagnosis of multiple myeloma, a cancer that forms in a type of white blood cell, a plasma cell.

She started her chemotherapy cycles and was later referred to Dr. Haematologist. Alma Calavera, a transplant specialist at The Medical City (TMC).

Dr. Alma Calavera with patient and husband at The Medical City Institute of Personalized Molecular Medicine. The medical city

One of the treatments she had to undergo was the bone marrow transplant, replacing the damaged bone marrow with healthy bone marrow stem cells.

Since 2016, the hospital, under its Institute of Personalized Molecular Medicine (IPMM), has performed more than 25 bone marrow transplants with an impressive result in patients with haematological cancers and other blood disorders.

TMC-IPMM & # 39; s Bone Marrow Transplant (BMT) program is led by Calavera and hematologist Dr. Norma Ona, supported by a multidisciplinary team of specialists.

With the help of health experts Mary believed that bone marrow transplantation can help her condition.

Mary received a bone marrow transplant at TMC in March 2017. The procedure went well and within one month after the transplant she was able to return to her work and to her usual activities.

Bone Marrow Transplant in The Medical City

Bone marrow transplantation was part of the standard treatment regimen for patients with certain malignancies of the blood and bone marrow, autoimmune diseases or other blood-related disorders.

A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells.

Calavera called the two types of stem cell transplantation: autologous and allogeneic. For autologous stem cell transplantation, the patient's own stem cells are removed from his bone marrow or peripheral blood before the graft. The cells are stored until they are needed for the transplant. For a patient with multiple myeloma such as Mary, the stored stem cells are returned to her blood after she has completed a high dose of chemotherapy treatment. The process is similar to getting a blood transfusion. This type of transplant is a standard treatment for patients with multiple myeloma.

In an allogeneic stem cell transplant, the patient receives blood-forming stem cells from another person – the donor. The best treatment results occur when the donor's cells closely match the patient's cell type and the donor is closely related to the patient, such as a sibling. Allogeneic transplantation is usually done for acute leukemia and other haematological malignancies. Both autologous and allogeneic stem cell transplants are performed at TMC.

"Our approach to patient care is personal and compassionate, here at TMC we also consider the financial concerns of the patient as part of our discussion at family meetings," said Calavera.

The institute has a special nursing department with positive pressure chambers for patients with a compromised immune system. These specially designed rooms provide good airflow to protect both the patient and the health professional.

Visit the Medical City website for more information.

NOTE: BrandNews articles are promotional features of our sponsors and not news articles from our editors.

.

Leave a comment

Send a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.